We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$22.1B
AUM Growth
+$1.21B
Cap. Flow
+$44.9M
Cap. Flow %
0.2%
Top 10 Hldgs %
18.25%
Holding
151
New
7
Increased
69
Reduced
69
Closed
6

Top Buys

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$167M
2
AKAM icon
Akamai
AKAM
+$145M
3
GNRC icon
Generac Holdings
GNRC
+$65.8M
4
CRNC icon
Cerence
CRNC
+$64.7M
5
LESL icon
Leslie's
LESL
+$49.5M

Sector Composition

Rank Sector Weight
1 Healthcare 24.09%
2 Technology 22.6%
3 Industrials 16.31%
4 Consumer Staples 12.62%
5 Financials 12.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
P
1
Everpure Inc
P
$23.3B
$564M 2.55%
17,317,710
-154,426
-0.9% -$4.48M
FTV icon
2
Fortive
FTV
$18.2B
$430M 1.95%
7,483,882
+144,749
+2% +$8.18M
AME icon
3
Ametek
AME
$53.8B
$417M 1.89%
2,833,360
-22,640
-0.8% -$3.1M
EW icon
4
Edwards Lifesciences
EW
$49.1B
$396M 1.79%
3,053,497
-16,775
-0.5% -$1.96M
AAP icon
5
Advance Auto Parts
AAP
$3.49B
$389M 1.76%
1,623,003
-19,740
-1% -$4.51M
IART icon
6
Integra LifeSciences
IART
$1.36B
$381M 1.73%
5,694,837
-32,400
-0.6% -$2.19M
STE icon
7
Steris
STE
$22.8B
$380M 1.72%
1,562,222
-52,089
-3% -$11.9M
WDAY icon
8
Workday
WDAY
$41.8B
$365M 1.65%
1,334,825
-97,151
-7% -$27M
WAT icon
9
Waters Corp
WAT
$37.4B
$362M 1.64%
972,735
-2,585
-0.3% -$904K
PANW icon
10
Palo Alto Networks
PANW
$255B
$347M 1.57%
3,741,258
-578,958
-13% -$50.1M
AJG icon
11
Arthur J. Gallagher & Co
AJG
$69.2B
$344M 1.56%
2,030,220
-126,527
-6% -$20.7M
GNRC icon
12
Generac Holdings
GNRC
$11.4B
$340M 1.54%
965,680
+158,591
+20% +$65.8M
ASAN icon
13
Asana
ASAN
$1.96B
$336M 1.52%
4,513,629
+348,784
+8% +$36.9M
EG icon
14
Everest Group
EG
$15.7B
$336M 1.52%
1,226,168
-7,095
-0.6% -$1.92M
ALGN icon
15
Align Technology
ALGN
$12.9B
$322M 1.46%
490,201
+65,251
+15% +$42M
NEWR
16
DELISTED
New Relic, Inc.
NEWR
$322M 1.46%
2,928,465
-1,297,955
-31% -$125M
ZS icon
17
Zscaler
ZS
$24.8B
$312M 1.41%
972,344
-15,990
-2% -$5.04M
XRAY icon
18
Dentsply Sirona
XRAY
$2.79B
$303M 1.37%
5,436,245
+733,144
+16% +$40.3M
MASI
19
DELISTED
Masimo
MASI
$284M 1.29%
969,687
-118,832
-11% -$33.8M
JBTM
20
JBT Marel
JBTM
$7.25B
$269M 1.22%
1,752,860
+6,230
+0.4% +$975K
TTC icon
21
Toro Company
TTC
$8.88B
$264M 1.2%
2,643,340
+53,444
+2% +$5.32M
SJM icon
22
J.M. Smucker
SJM
$13.6B
$254M 1.15%
1,872,754
-20,495
-1% -$2.61M
CLX icon
23
Clorox
CLX
$12.1B
$249M 1.13%
1,430,671
-20,660
-1% -$3.44M
TW icon
24
Tradeweb Markets
TW
$23B
$249M 1.13%
2,487,672
-405,090
-14% -$37.4M
LESL icon
25
Leslie's
LESL
$8.45M
$249M 1.13%
525,596
+114,663
+28% +$49.5M

Similar funds

Champlain Investment Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Champlain Investment Partners held 151 positions worth $22.1B, up 5.8% from $20.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Champlain Investment Partners's Q4 2021 filing shows 7 new, 69 increased, 69 reduced and 6 closed positions. Its largest new stake was Akamai: 1,320,560 shares worth $155M. The largest sale was Molson Coors Class B, an estimated $147M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • Champlain Investment Partners's largest Q4 2021 buy was Akamai: 1,320,560 shares worth $155M.
  • Champlain Investment Partners added most to Freshpet in Q4 2021, an estimated $167M increase.
  • Champlain Investment Partners's biggest Q4 2021 reduction was New Relic, Inc., cutting an estimated $125M.
  • Champlain Investment Partners fully exited Molson Coors Class B in Q4 2021, selling an estimated $147M.
  • Champlain Investment Partners's ten largest holdings make up 18% of its $22.1B portfolio in Q4 2021.
  • Champlain Investment Partners opened 7 new positions and closed 6 in Q4 2021.
  • Champlain Investment Partners's portfolio value rose 5.8% quarter-over-quarter to $22.1B.

Based on Champlain Investment Partners's 13F filing for Q4 2021, filed 10 Feb 2022.